MYCN AMPLIFICATION PREDICTED A WORSE PROGNOSIS IN PATIENTS WITH LOWER-GRADE IDH-MUTANT GLIOMAS AND WAS RELATED TO THE EPITHELIOID HISTOLOGICAL FEATURES

被引：0
|
作者：
Xi, S. [1 ]
Xie, X. [1 ]
Qin, Y. [1 ]
Lu, J. [1 ]
机构：
[1] Sun yat sen Univ Canc Ctr, Guangzhou, Peoples R China
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.346
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P18.30.B
引用
收藏
页码：V104 / V104
页数：1
相关论文
共 50 条
  • [1] Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
    Lee, Kwanghoon
    Kim, Seong-Ik
    Kim, Eric Eunshik
    Shim, Yu-Mi
    Won, Jae-Kyung
    Park, Chul-Kee
    Choi, Seung Hong
    Yun, Hongseok
    Lee, Hyunju
    Park, Sung-Hye
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
    Kwanghoon Lee
    Seong-Ik Kim
    Eric Eunshik Kim
    Yu-Mi Shim
    Jae-Kyung Won
    Chul-Kee Park
    Seung Hong Choi
    Hongseok Yun
    Hyunju Lee
    Sung-Hye Park
    Scientific Reports, 13
  • [3] c-Met Expression Is a Useful Marker for Prognosis Prediction in IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas
    Ohba, Shigeo
    Yamada, Yasuhiro
    Murayama, Kazuhiro
    Sandika, Eriel
    Sasaki, Hikaru
    Yamada, Seiji
    Abe, Masato
    Hasegawa, Mitsuhiro
    Hirose, Yuichi
    WORLD NEUROSURGERY, 2019, 126 : E1042 - E1049
  • [4] The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas
    Pareira, Eriel Sandika
    Shibuya, Makoto
    Ohara, Kentaro
    Nakagawa, Yu
    Kanazawa, Tokunori
    Kamamoto, Dai
    Kato, Yasutaka
    Arai, Eri
    Aimono, Eriko
    Yoshida, Kazunari
    Nishihara, Hiroshi
    Kanai, Yae
    Sasaki, Hikaru
    BRAIN TUMOR PATHOLOGY, 2022, 39 (02) : 79 - 87
  • [5] The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas
    Eriel Sandika Pareira
    Makoto Shibuya
    Kentaro Ohara
    Yu Nakagawa
    Tokunori Kanazawa
    Dai Kamamoto
    Yasutaka Kato
    Eri Arai
    Eriko Aimono
    Kazunari Yoshida
    Hiroshi Nishihara
    Yae Kanai
    Hikaru Sasaki
    Brain Tumor Pathology, 2022, 39 : 79 - 87
  • [6] CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma
    Richardson, Timothy E.
    Walker, Jamie M.
    CLINICAL NEUROPATHOLOGY, 2021, 40 (04) : 209 - 214
  • [7] NEURO-ONCOLOGICAL SUPERIORITY OF SUPRATOTAL RESECTION AGAINST TOTAL RESECTION FOR IDH-MUTANT LOWER-GRADE GLIOMAS
    Gallotti, A. L.
    Rossi, M.
    Conti Nibali, M.
    Sciortino, T.
    Gay, L. G.
    Puglisi, G.
    Leonetti, A.
    Bello, L.
    NEURO-ONCOLOGY, 2024, 26 : V20 - V21
  • [8] MOLECULAR-BASED GRADING IN IDH-MUTANT LOWER GRADE GLIOMAS
    Aldape, Kenneth
    Zadeh, Gelareh
    Sulman, Erik
    NEURO-ONCOLOGY, 2014, 16
  • [9] Epidemiological analysis of adult-type diffuse lower-grade gliomas and incidence and prevalence estimates of diffuse IDH-mutant gliomas in France
    Bauchet, Luc
    Rigau, Valerie
    Mathon, Bertrand
    Darlix, Amelie
    NEUROCHIRURGIE, 2025, 71 (03)
  • [10] Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas
    Autry, Adam W.
    Lafontaine, Marisa
    Jalbert, Llewellyn
    Phillips, Elizabeth
    Phillips, Joanna J.
    Villanueva-Meyer, Javier
    Berger, Mitchel S.
    Chang, Susan M.
    Li, Yan
    JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (01) : 43 - 52
12345